These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 27041209)
41. Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. Boyanapalli SS; Li W; Fuentes F; Guo Y; Ramirez CN; Gonzalez XP; Pung D; Kong AN Pharmacol Res; 2016 Dec; 114():175-184. PubMed ID: 27818231 [TBL] [Abstract][Full Text] [Related]
42. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer. Mishra NK; Guda C Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671 [TBL] [Abstract][Full Text] [Related]
43. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis. Simmonds P; Loomis E; Curry E Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290 [TBL] [Abstract][Full Text] [Related]
44. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908 [TBL] [Abstract][Full Text] [Related]
45. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells. Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304 [TBL] [Abstract][Full Text] [Related]
46. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
47. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Li B; Shi XB; Nori D; Chao CK; Chen AM; Valicenti R; White Rde V Prostate; 2011 May; 71(6):567-74. PubMed ID: 20878953 [TBL] [Abstract][Full Text] [Related]
48. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract. Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731 [TBL] [Abstract][Full Text] [Related]
49. Epigenetic factors of individual radiosensitivity and adaptive capacity. Kravets AP; Sokolova DA Int J Radiat Biol; 2020 Aug; 96(8):999-1007. PubMed ID: 32396015 [No Abstract] [Full Text] [Related]
50. Ionizing Radiation-Induced Epigenetic Modifications and Their Relevance to Radiation Protection. Belli M; Tabocchini MA Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825382 [TBL] [Abstract][Full Text] [Related]
51. Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. Fortin JP; Hansen KD Genome Biol; 2015 Aug; 16(1):180. PubMed ID: 26316348 [TBL] [Abstract][Full Text] [Related]
52. Possible applications of biotechnology to radiotherapy. Weichselbaum RR Eur J Cancer; 1991; 27(4):405-7. PubMed ID: 1828165 [No Abstract] [Full Text] [Related]
54. Cured in a FLASH: Reducing Normal Tissue Toxicities Using Ultra-High-Dose Rates. Al-Hallaq H; Cao M; Kruse J; Klein E Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):257-260. PubMed ID: 31047621 [No Abstract] [Full Text] [Related]
55. CRPC Membrane-Camouflaged, Biomimetic Nanosystem for Overcoming Castration-Resistant Prostate Cancer by Cellular Vehicle-Aided Tumor Targeting. Lu K; Li Z; Hu Q; Sun J; Chen M Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408983 [TBL] [Abstract][Full Text] [Related]